Tag Archives: FDA

FDA Reclassification of Electroconvulsive Therapy Devices

Here are some facts about ECT which the FDA does not want you to know. Continue reading

Posted in Big Muddy River Newsletter, Press Releases | Tagged , , | Comments Off on FDA Reclassification of Electroconvulsive Therapy Devices

Shock and Awe – the Latest Psychiatric Abuse of Children

The psychiatric industry is introducing electrical “stimulation” of children’s brains as a socially acceptable gradient to just plain shocking them into good behavior. Continue reading

Posted in Big Muddy River Newsletter, Press Releases | Tagged , , , , , | Comments Off on Shock and Awe – the Latest Psychiatric Abuse of Children

Chanting the Chantix Mantra

Chantix is a psychiatric drug which can cause suicidal thoughts, self-harm, and homicidal thoughts. Continue reading

Posted in Big Muddy River Newsletter, Press Releases | Tagged , , , , , , | Comments Off on Chanting the Chantix Mantra

The Psychiatric Scientific Double Standard

“evidence-based science” Continue reading

Posted in Big Muddy River Newsletter, Press Releases | Tagged , , , , | Comments Off on The Psychiatric Scientific Double Standard

Hear This — Zone Out on Zonisamide

We suggest that funding only be provided for workable medical treatments. Continue reading

Posted in Big Muddy River Newsletter, Press Releases | Tagged , , , , | Comments Off on Hear This — Zone Out on Zonisamide

Knock Yourself Out with Spravato (Esketamine)

Any form of ketamine used to treat so-called depression is unethical and harmful. Continue reading

Posted in Big Muddy River Newsletter, Press Releases | Tagged , , , , , , , , | Comments Off on Knock Yourself Out with Spravato (Esketamine)

Tranq Your Dog

The psychiatric industry makes a concerted effort to create new patient classes. Continue reading

Posted in Big Muddy River Newsletter, Press Releases | Tagged , , | Comments Off on Tranq Your Dog

Rexulti Fails to Get Results

REXULTI (generic brexpiprazole) is a prescription psychiatric drug from Otsuka Pharmaceutical Company and Lundbeck pharmaceutical company. Although it failed Phase II clinical trials for attention-deficit hyperactivity disorder (ADHD), it was approved by the U.S. Food and Drug Administration (FDA) in … Continue reading

Posted in Big Muddy River Newsletter, Press Releases | Tagged , , , , , , , , | Comments Off on Rexulti Fails to Get Results

You May Be Seeing Things That Aren’t Really There

But You Can See The Wool Being Pulled Over Your Eyes Hallucinations and delusions are possible complications of Parkinson’s disease (PD). They are often referred to as PD psychosis. It’s estimated to occur in up to 50 percent of people … Continue reading

Posted in Big Muddy River Newsletter, Press Releases | Tagged , , , , | Comments Off on You May Be Seeing Things That Aren’t Really There

Smoking is So Last Year

“Given the disproportionate burden of tobacco health harms in psychiatric patients, e-cigarettes are being considered as a potential tool for harm reduction.” E-cigs are battery-powered devices that typically contain nicotine, flavorings, and other chemicals. The liquid is heated into an … Continue reading

Posted in Big Muddy River Newsletter, Press Releases | Tagged , , | Comments Off on Smoking is So Last Year